Circulating and adipose levels of adipokines associated with insulin sensitivity in nonobese subjects with type 2 diabetes

24Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

Abstract

Context: The adipokines chemerin, dipeptidyl peptidase 4, and adiponectin influence insulin sensitivity. Whether their circulating levels and adipose secretion are altered in nonobese individuals with type 2 diabetes mellitus (T2DM) is unknown. Objective: The objective of this study was to investigate SC adipose secretion and serum levels of the three adipokines in relation to T2DM features. Design: Fourteen nonobese T2DM and 13 healthy men were investigated. Insulin sensitivity and glucose control were assessed by hyperinsulinemic euglycemic clamp, homeostasis model assessment, and glycated hemoglobin. Main Outcome Measure: Association of circulating and adipose-secreted adipokines with fat cell volume and insulin sensitivity was measured. Participants: Volunteers in an outpatient academic clinic participated. Results: Although adipose secretion was similar between the groups, serum chemerin was higher (70 ± 10 vs 50 ± 1 ng/ml; P

Cite

CITATION STYLE

APA

Andersson, D. P., Laurencikiene, J., Acosta, J. R., Rydén, M., & Arner, P. (2016). Circulating and adipose levels of adipokines associated with insulin sensitivity in nonobese subjects with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 101(10), 3765–3771. https://doi.org/10.1210/jc.2016-1883

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free